Tiopronin Patent Expiration
Tiopronin is Used for preventing cystine stone formation in individuals with severe homozygous cystinuria. It was first introduced by Mission Pharmacal Co
Tiopronin Patents
Given below is the list of patents protecting Tiopronin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Thiola Ec | US11458104 | Enteric coated tiopronin tablet | Nov 14, 2038 | Mission Pharmacal |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Tiopronin's patents.
Latest Legal Activities on Tiopronin's Patents
Given below is the list recent legal activities going on the following patents of Tiopronin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed Critical | 04 Oct, 2022 | US11458104 |
| Application ready for PDX access by participating foreign offices Critical | 04 Oct, 2022 | US11458104 |
| Patent Issue Date Used in PTA Calculation Critical | 04 Oct, 2022 | US11458104 |
| Email Notification Critical | 15 Sep, 2022 | US11458104 |
| Issue Notification Mailed Critical | 14 Sep, 2022 | US11458104 |
| Dispatch to FDC | 12 Sep, 2022 | US11458104 |
| Application Is Considered Ready for Issue Critical | 12 Sep, 2022 | US11458104 |
| Email Notification Critical | 05 Aug, 2022 | US11458104 |
| Mailing Corrected Notice of Allowability | 05 Aug, 2022 | US11458104 |
| Corrected Notice of Allowability | 01 Aug, 2022 | US11458104 |
Tiopronin's Family Patents
Explore Our Curated Drug Screens
Tiopronin Generic API Manufacturers
Several generic applications have been filed for Tiopronin. The first generic version for Tiopronin was by Teva Pharmaceuticals Usa Inc and was approved on Apr 26, 2021. And the latest generic version is by Teva Pharmaceuticals Inc and was approved on Jul 22, 2024.
Given below is the list of companies who have filed for Tiopronin generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL
Amneal Eu Ltd has filed for 1 generic for Tiopronin. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 300MG | tablet, delayed release | Prescription | ORAL | AB | Aug 15, 2023 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
2. ENDO OPERATIONS
Endo Operations Ltd has filed for 2 different strengths of generic version for Tiopronin. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, delayed release | Prescription | ORAL | AB | Feb 24, 2023 |
| 300MG | tablet, delayed release | Prescription | ORAL | AB | Feb 24, 2023 |
3. TEVA PHARMS INC
Teva Pharmaceuticals Inc has filed for 2 different strengths of generic version for Tiopronin. Given below are the details of the strengths of this generic introduced by Teva Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 300MG | tablet, delayed release | Prescription | ORAL | AB | Jul 22, 2024 |
| 100MG | tablet, delayed release | Prescription | ORAL | AB | Jul 22, 2024 |
4. TEVA PHARMS USA INC
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Tiopronin. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Prescription | ORAL | AB | Apr 26, 2021 |
5. TORRENT
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Tiopronin. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, delayed release | Prescription | ORAL | AB | Jan 30, 2024 |
| 300MG | tablet, delayed release | Prescription | ORAL | AB | Jan 30, 2024 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||